The Key Players in The Global Proteomics Market 2015-2019

Thursday 14 May 2015, Amsterdam

Market Research Report Press Release

The report recognizes the following companies as the key players in Global Proteomics Market 2015-2019: Agilent Technologies, Danaher Corp and Thermo Fisher Scientific Inc.

Other Prominent Vendors in the market are: AB Sciex, Abbott Laboratories, Affymetrix, AMS Biotechnology, Avacta Life Sciences, BD Biosciences, Biocompare, Bio-Rad , Bio-WORLD, Bruker Daltonics, Caprion Proteomics, Cellzome, Dionex, GE Healthcare Life Sciences, Flowgen Bioscience , Fluidigm, Illumina , MRM Proteomics, Ocular Proteomics, Perkin Elmer, Pragati Biomedical, Proteomics International, Proteomics Sciences, Roche Diagnostics, Sera Proteomics, SGS, Shimadzu, Sigma-Aldrich, Waters and Xencor

The report said: “Advances in mass spectrometry have become a major trend for the growth of the market as the data provided by these instruments are highly accurate and extensively used for data analysis.”

According to the report, an increase in demand for personalized medicines is one of the major contributors to the growth of the market. Personalized medicines are developed according to the genetic make-up of an individual, and today are extensively used for treatment of diabetes and cancers such as lung cancer.

Further, the report states that the one of the main challenges is regulatory hurdles pertaining to quality of instruments and approval of devices for research purposes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Global Proteomics Market 2015-2019

Global Proteomics Market 2015-2019

Publish date : April 2015
Report code : ASDR-193681
Pages : 80 Media contact: S. Koopman - Marketing and Communications / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E :

 back to News